戻る
Neurizon Therapeutics Limited (NUZTF)価格
NUZTF 株価推移チャート
NUZTF 収入
Neurizon Therapeutics Limited
$0.09
-10%
$-0.01
本日現在の状況：Jan 23, 15:37:19 GMT-5
Earnings FAQ
NUZTFの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Neurizon Therapeutics Limited NUZTFの前四半期の収益はどうでしたか？
Neurizon Therapeutics Limitedの収益見積もりはいくらですか？
Neurizon Therapeutics Limitedの収益品質スコアはどれくらいですか？
Neurizon Therapeutics Limitedはいつ収益を報告しますか？
Neurizon Therapeutics Limitedの予想収益はいくらですか？
Neurizon Therapeutics Limitedは収益予想を上回りましたか？
主要データ
前終値
$0.1
始値
$0.09
当日レンジ
$0.09 - $0.09
52週レンジ
$0.0686 - $0.1197
取引高
--
平均取引高
4
1株当たり利益(TTM)
-0.02
配当利回り
--
時価総額
$55.3M
NUZTFとは何ですか？
Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-10-05. The firm is engaged in advancing treatments for neurodegenerative diseases. The firm is focused on developing its lead drug candidate, NUZ-001, for the treatment of Amyotrophic Lateral Sclerosis (ALS), which is the common form of motor neuron disease. ALS is a devastating neurodegenerative condition that primarily affects nerve cells that control voluntary muscles.